T0	Participants 206 273	patients and in dogs with experimentally induced heart failure (HF)
T1	Participants 556 595	both patients and dogs with chronic HF.
T2	Participants 616 740	Six dogs with microembolizations-induced HF and 9 HF patients underwent CCM leads and generator (OPTIMIZER II) implantation.